Navigation Links
Health Officials Inquire Into OraQuick HIV Tests

The US federal health agents have launched an inquiry into the oral HIV tests which have given false results. The use of the product has been stopped at the California and New York health centers. The rapid OraQuick Advance // saliva test reportedly gives a result in just 20 minutes. The test had gained popularity as blood samples are not called for, in addition to its speed. (

Complaints are being investigated by officials belonging to the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration. The recent accuracy levels of the test have been at 99.1%, which may lead to significant differences when a large group of people are tested. The FDA is expected to take corrective action after the results of the inquiry are revealed. The OraSure Technologies of Bethlehem, the manufacturer of the test is cooperating with the investigation. (

The kit can also conduct blood tests, and the high false positives are reported to be only from the saliva test. Due to its popularity, as many as 6,000 more people underwent the test during the course of 2005. The tests have been stopped by the New York City health officials after instances of false positives. The follow-up laboratory tests threw light on the false positives.
'"/>




Page: 1

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it had joined the Pharmaceutical Supply Chain ... organization to unite pharmaceutical and healthcare companies that share a vision of better, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... California Senate Bill ... payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical ... Institute (WCRI) . , According to the study, medical payments per claim in California ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... LAVAL, Quebec , Dec. 8, 2016 /PRNewswire/ ... and TSX: VRX) ("Valeant") today announced positive ... vehicle-controlled clinical study to assess the safety and ... in the treatment of plaque psoriasis. ... adult subjects with moderate to severe psoriasis, IDP-118 ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: